US

Tachyum lands $25 mln Series A

Silicon Valley-based Tachyum Inc, a cloud chip startup, has raised $25 million in Series A funding. IPM Group led the round.

AblaCare takes in Series A

Paris-based AblaCare, a medical device firm focused on women's health and fertility care, has secured 10 million euros in Series A funding. The investor was Sofinnova Partners.

IGM Biosciences amasses $102 mln Series C

Mountain View, California-based IGM Biosciences Inc, a biotech firm focused on developing engineered IgM antibodies for therapeutic use, has raised $102 million in Series C financing. The investors included Redmile Group, Janus Henderson Investors and Vivo Capital.

BioNTech procures $325 mln Series B

BioNTech SE, a German biotech company focused on treating cancer and other serious diseases, has raised $325 million in Series B funding. Fidelity Management & Research Company was the lead investor.

Avestria targets $50 mln for inaugural fund

Avestria Ventures is seeking to raise $50 million for its debut fund, according to an SEC filing. The California-based venture firm invests in early-stage women's health and life science companies.

Maniv Mobility racks up $100 mln for second fund: Reuters

Maniv Mobility, an Israeli venture firm focused on mobility tech, has raised $100 million for its second fund, reported Reuters. The investors in Maniv's fund include Alliance Ventures, the strategic venture capital arm of Renault-Nissan-Mitsubishi, Aptiv, BMW i Ventures, Hyundai Motor Group, Lear Corp, LG Electronics, Shell Ventures and Valeo.

GNS Healthcare inks $23 mln Series D

Cambridge, Massachusetts-based GNS Healthcare, a precision medicine company, has raised $23 million in Series D funding round. Cigna Ventures led the round.

Revolution Medicines nabs $100 mln Series C

Redwood City, California-based Revolution Medicines Inc, a developer of medicines for cancer patients, has secured $100 million in Series C financing. The investors included Boxer Capital of the Tavistock Group, Cormorant Capital, Deerfield Management, Fidelity Management & Research Company, Vivo Capital, Biotechnology Value Fund, Nextech Invest, Schroder Adveq, The Column Group, Third Rock Ventures and Casdin Capital.

Amp Human inks funding

Park City, Utah-based Amp Human, a maker of products for athletes, has secured an undisclosed amount of funding. Lance Armstrong's venture firm Next Ventures was the lead investor.

Connected Robotics nets Series A

Connected Robotics, a Japanese developer of specialized robot systems for cooking in restaurant kitchens, has raised 850 million yen (about $7.8 million) in Series A funding. The lead backer was Global Brain Corporation.